Wade G W & Inc Verve Therapeutics, Inc. Transaction History
Wade G W & Inc
- $3.08 Billion
- Q4 2023
A detailed history of Wade G W & Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 259,626 shares of VERV stock, worth $1.24 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
259,626
Previous 259,626
-0.0%
Holding current value
$1.24 Million
Previous $3.44 Million
5.11%
% of portfolio
0.12%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
173Shares Held
74.7MCall Options Held
115KPut Options Held
144K-
Alphabet Inc. Mountain View, CA12.3MShares$59.2 Million3.79% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$25.2 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.53MShares$21.7 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.87MShares$18.5 Million0.01% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $287M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...